Paloma Partners Management Co bought a new position in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 45,756 shares of the company's stock, valued at approximately $545,000. Paloma Partners Management Co owned approximately 0.11% of Varex Imaging at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Vanguard Group Inc. increased its stake in Varex Imaging by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 4,612,324 shares of the company's stock valued at $83,483,000 after purchasing an additional 29,511 shares in the last quarter. Price T Rowe Associates Inc. MD purchased a new position in Varex Imaging in the 1st quarter valued at approximately $207,000. Comerica Bank increased its stake in Varex Imaging by 98.1% in the 1st quarter. Comerica Bank now owns 37,586 shares of the company's stock valued at $680,000 after purchasing an additional 18,615 shares in the last quarter. First Hawaiian Bank increased its stake in Varex Imaging by 32.9% in the 2nd quarter. First Hawaiian Bank now owns 31,049 shares of the company's stock valued at $457,000 after purchasing an additional 7,686 shares in the last quarter. Finally, Wedge Capital Management L L P NC grew its holdings in Varex Imaging by 3.9% during the 2nd quarter. Wedge Capital Management L L P NC now owns 81,579 shares of the company's stock valued at $1,202,000 after buying an additional 3,068 shares during the last quarter.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on VREX. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a report on Wednesday, November 27th. B. Riley assumed coverage on Varex Imaging in a research report on Friday, August 23rd. They issued a "buy" rating and a $21.00 target price on the stock.
Get Our Latest Stock Report on VREX
Varex Imaging Stock Down 0.5 %
Shares of NASDAQ:VREX traded down $0.08 during trading on Wednesday, hitting $16.29. The company's stock had a trading volume of 470,141 shares, compared to its average volume of 507,157. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.97 and a current ratio of 3.32. Varex Imaging Co. has a fifty-two week low of $10.19 and a fifty-two week high of $21.50. The stock's 50-day moving average price is $13.53 and its two-hundred day moving average price is $13.54. The company has a market capitalization of $669.52 million, a PE ratio of -13.92 and a beta of 0.60.
Varex Imaging Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Further Reading
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.